20/10/2018 - The research-based pharmaceutical company GlaxoSmithKline, headquartered in Uk, expands its presence in San Polo di Torrile (Parma) with a 1,500 sq. m plant devoted to production and packaging of a medicine for Hiv-treatment, investing 30 million euro.
The Plant Director Maria Chiara Amadei stated: “Parma has given an important contribute (…) in the deep technological and innovative transformation that is revolutionizing the health sector at global level”.